TY  - JOUR
AU  - García-Martín, Adela
AU  - Navarrete, Carmen
AU  - Garrido-Rodríguez, Martin
AU  - Prados, María E
AU  - Caprioglio, Diego
AU  - Appendino, Giovanni
AU  - Muñoz, Eduardo
PY  - 2021
DO  - 10.1016/j.biopha.2021.112007
UR  - https://hdl.handle.net/10668/25786
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AB  - Some cannabinoids showed anti-inflammatory and antifibrotic activities. EHP-101 is an oral lipidic formulation of the novel non-psychotropic cannabidiol aminoquinone VCE-004.8, which showed antifibrotic activity in murine models of systemic sclerosis...
LA  - en
KW  - Angiotensin II
KW  - Cannabinoids
KW  - Cardiac Fibrosis
KW  - E2F
KW  - EHP-101
KW  - Administration, Oral
KW  - Angiotensin II
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Cannabidiol
KW  - Fibroblasts
KW  - Fibrosis
KW  - Gene Expression Regulation
KW  - Inflammation
KW  - Losartan
KW  - Male
KW  - Mice
KW  - Mice, Inbred C57BL
KW  - Myocardium
KW  - Myofibroblasts
TI  - EHP-101 alleviates angiotensin II-induced fibrosis and inflammation in mice.
TY  - research article
VL  - 142
ER  -